Study ID: PM013

Study Title

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxoneֲ®.

Teva Identifier

PM013

ClinicalTrials.gov Identifier

NCT00220922

Study Status

Completed

Trial Condition(s)

Multiple Sclerosis

Interventions

Procedure: Alcohol Wipes vs. No Alcohol Wipes

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

08/01/2004 - 02/01/2006

Phase

Phase 4

Study Type

Interventional